Fusion Pharmaceuticals Inc. today announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 68,000 shares of its common stock to two employees outside Fusion’s 2020 Stock Option and Incentive Plan.
